Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Greater access to obesity drugs puts spotlight on safety Michael Monostra
-
- Autoimmune thyroid disease risk decreases after rheumatoid arthritis diagnosis Michael Monostra
- Body composition changes at different stages of therapy for transgender boys vs. girls Michael Monostra
- Exposure to endocrine-disrupting chemicals may lower odds for achieving pregnancy Michael Monostra
- FDA clears wearable vibration belt for postmenopausal women with osteopenia
- Hearing loss with teprotumumab more likely for adults with baseline hearing dysfunction Michael Monostra
- High hematocrit levels rare for adults receiving gender-confirming testosterone therapy Michael Monostra
- Immunotherapy to treat people with type 1 diabetes genotype granted fast track designation
- Iodized salt: Celebrating the centennial of a major US public health triumph Elizabeth N. Pearce, MD, MSc
-
- Is an at-home menopause test useful for women? Experts weigh in Regina Schaffer
- Maternal diabetes increases children’s risk for congenital heart defects Michael Monostra
- Noninvasive tests may fail to detect liver fibrosis, especially among Black adults Michael Monostra
- Phthalate exposure linked to higher odds for preterm birth, low birth weight Michael Monostra
- Q&A: Increased awareness may boost uptake of inhaled insulin Michael Monostra; Thomas Blevins, MD, FACE; Michael J. Haller, MD
- Transgender young people report worse mental health than general population Michael Monostra
- Type 2 diabetes remission more likely with gastric bypass vs. sleeve gastrectomy Michael Monostra
- VIDEO: Bone turnover markers useful for monitoring effects of osteoporosis therapies Jill Rollet
-
- VIDEO: Many options for anti-obesity medications in the pipeline Michael Monostra; Ania M. Jastreboff, MD, PhD
- VIDEO: Many pathways to diabetes remission Erin T. Welsh, MA; Richard E. Pratley, MD
- Weight loss in year after diagnosis linked to greater odds of type 2 diabetes remission Michael Monostra
- Weight management treatments remain underused despite their effectiveness Andrew (Drew) Rhoades
- Q&A: What to know about ultra-long-acting insulins Susan Weiner, MS, RDN, CDN, CDCES, FADCES; Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM